Document Type
Response or Comment
Publication Date
6-14-2023
Recommended Citation
Stahl, Maximilian; Abdel-Wahab, Omar; Wei, Andrew H.; Savona, Michael R.; Xu, Mina L.; Xie, Zhuoer; Taylor, Justin; Starczynowski, Daniel; Sanz, Guillermo F.; Sallman, David A.; Santini, Valeria; Roboz, Gail J.; Patnaik, Mrinal M.; Padron, Eric; Odenike, Olatoyosi; Nazha, Aziz; Nimer, Stephen D.; Majeti, Ravindra; Little, Richard F.; Gore, Steven; List, Alan F.; Kutchroo, Vijay; Komrokji, Rami S.; Kim, Tae Kon; Kim, Nina; Hourigan, Christopher S.; Hasserjian, Robert P.; Halene, Stephanie; Griffiths, Elizabeth A.; Greenberg, Peter L.; Figueroa, Maria; Fenaux, Pierre; Efficace, Fabio; DeZern, Amy E.; Della Porta, Matteo G.; Daver, Naval G.; Churpek, Jane E.; Carraway, Hetty E.; Brunner, Andrew M.; Borate, Uma; Bennett, John M.; Bejar, Rafael; Boultwood, Jacqueline; Loghavi, Sanam; Bewersdorf, Jan Philipp; Platzbecker, Uwe; Steensma, David P.; Sekeres, Mikkael A.; Buckstein, Rena J.; and Zeidan, Amer M., "An Agenda to Advance Research in Myelodysplastic Syndromes: A TOP 10 Priority List From the First International Workshop in MDS" (2023). Department of Medical Oncology Faculty Papers. Paper 242.
https://jdc.jefferson.edu/medoncfp/242
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.
PubMed ID
36260702
Language
English
Comments
This commentary is the author's final published version in Blood Advances, Volume 7, Issue 12, 27 June 2023, Pg. 2709 - 2714.
The published version is available at https://doi.org/10.1182/bloodadvances.2022008747. Copyright © 2023 by American Society of Hematology.